Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Parameter in fulminant hepatitis].

T Moritoh1, M Kuroda, T Takagi

  • 12nd Department of Internal Medicine, Fukushima Medical College.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smectic Liquid-Crystalline Structure of Skyrmions in Chiral Magnet Co_{8.5}Zn_{7.5}Mn_{4}(110) Thin Film.

Physical review letters·2019
Same author

Microscopic gain analysis of modulation-doped GeSn/SiGeSn quantum wells: epitaxial design toward high-temperature lasing.

Optics express·2019
Same author

Si-based Mach-Zehnder wavelength/mode multi/demultiplexer for a WDM/MDM transmission system.

Optics express·2018
Same author

Location, size and age at onset of metamorphosis in the Japanese eel Anguilla japonica.

Journal of fish biology·2018
Same author

Risk of haemolytic uraemic syndrome caused by shiga-toxin-producing Escherichia coli infection in adult women in Japan.

Epidemiology and infection·2015
Same author

A knotty problem of a central venous catheter.

Journal of anesthesia·2013

Serum complement hemolytic activity (CH50) and prothrombin time (PTT) can help distinguish between acute and subacute fulminant hepatitis. These markers offer valuable insights into disease severity and patient prognosis in hepatitis cases.

Area of Science:

  • Hepatology
  • Clinical Biochemistry
  • Immunology

Context:

  • Fulminant hepatitis (FH) presents a critical diagnostic challenge, particularly in differentiating acute and subacute presentations.
  • Accurate prognostic markers are essential for timely intervention and improved patient outcomes in severe liver disease.
  • Existing diagnostic tools may not fully capture the nuances of disease progression in fulminant hepatitis.

Purpose:

  • To evaluate the utility of serum complement hemolytic activity (CH50) and plasma prothrombin time (PTT) as biomarkers in patients with varying severities of hepatitis.
  • To investigate the correlation between CH50 levels, PTT, and disease severity in typical acute hepatitis (AH-T), severe acute hepatitis (AH-S), and fulminant hepatitis (FH).
  • To determine if CH50 and PTT can effectively differentiate between the acute and subacute types of fulminant hepatitis.

Related Experiment Videos

Summary:

  • This study analyzed CH50 and PTT in 31 patients with AH-T, AH-S, and FH (11 acute, 11 subacute).
  • Survival rates varied significantly: 100% for AH-S, 45.5% for acute FH, and 9.1% for subacute FH.
  • Lower CH50 levels correlated with increased disease severity and PTT (r=0.809). CH50 changes were slower than PTT in FH and AH-S, which often presented with prolonged PTT and normal CH50.
  • CH50 and PTT demonstrated potential as differential markers for subacute versus acute fulminant hepatitis.

Impact:

  • The findings suggest that CH50 and PTT can serve as valuable, accessible biomarkers for distinguishing between acute and subacute fulminant hepatitis.
  • This differentiation can aid clinicians in refining prognoses and tailoring treatment strategies for patients with severe hepatitis.
  • The study highlights the potential of combining immunological (CH50) and coagulation (PTT) parameters for enhanced diagnostic accuracy in critical liver conditions.